Similar Papers

Paper Title
Journal
Date
Author
Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma.
Olorunseun O Ogunwobi ... Chen Liu
Journal of Gastroenterology and Hepatology | VOL. 27
Olorunseun O Ogunwobi, et. al.Olorunseun O Ogunwobi ... Chen Liu
21 Feb 2012
SOX9/MKLN1-AS Axis Induces Hepatocellular Carcinoma Proliferation and Epithelial-Mesenchymal Transition.
Chao Guo ... Jianming Liu
Biochemical Genetics | VOL. 60
Chao Guo, et. al.Chao Guo ... Jianming Liu
09 Feb 2022
AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma.
Jiakang Zhang ... Xinhui Liu
Cancers | VOL. 14
Jiakang Zhang, et. al.Jiakang Zhang ... Xinhui Liu
22 Sep 2022
An Atypical System for Studying Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
Dhiviya Vedagiri ... Krishnan Harinivas Harshan
Scientific Reports | VOL. 6
Dhiviya Vedagiri, et. al.Dhiviya Vedagiri ... Krishnan Harinivas Harshan
20 May 2016
View more papers

More From: Molecular cancer therapeutics

Paper Title
Journal
Date
Author
Co-blocking TIGIT and PVRIG using a novel bispecific antibody enhances anti-tumor immunity.
Yuan Lin ... Cheng Liao
Molecular cancer therapeutics | VOL. -
Yuan Lin, et. al.Yuan Lin ... Cheng Liao
24 Jan 2025
Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer Models.
Shan Lu ... Henning Willers
Molecular cancer therapeutics | VOL. -
Shan Lu, et. al.Shan Lu ... Henning Willers
21 Jan 2025
Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer Models.
Shan Lu ... Henning Willers
Molecular cancer therapeutics | VOL. -
Shan Lu, et. al.Shan Lu ... Henning Willers
21 Jan 2025
PI3K/mTOR dual inhibitor GSK458 and arsenic trioxide exert synergistic anti-tumor effects against ovarian clear cell carcinoma.
Yan Wang ... Tadashi Kimura
Molecular cancer therapeutics | VOL. -
Yan Wang, et. al.Yan Wang ... Tadashi Kimura
21 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.